Jeff Kutok

562 total citations
10 papers, 428 citations indexed

About

Jeff Kutok is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeff Kutok has authored 10 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeff Kutok's work include Advanced Breast Cancer Therapies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Jeff Kutok is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Jeff Kutok collaborates with scholars based in United States, Denmark and Italy. Jeff Kutok's co-authors include William H. Sharfman, Bernhard J. Eigl, Charles M. Rudin, Georgios Skliris, Scott Gettinger, Anne Lynn S. Chang, Joi Dunbar, Wilson H. Miller, Karl D. Lewis and Raoul Tibes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jeff Kutok

10 papers receiving 416 citations

Peers

Jeff Kutok
Neelima Reddy United States
Julie C. Porcher United States
Luk Cox Belgium
Jean Lopategui United States
Justus Duyster Germany
Elisa Schipper Germany
Zhiming Dong China
Yoshiaki Chinen Japan
Awatif Al‐Nafussi United Kingdom
Maria Rosaria Sapienza Italy
Neelima Reddy United States
Jeff Kutok
Citations per year, relative to Jeff Kutok Jeff Kutok (= 1×) peers Neelima Reddy

Countries citing papers authored by Jeff Kutok

Since Specialization
Citations

This map shows the geographic impact of Jeff Kutok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Kutok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Kutok more than expected).

Fields of papers citing papers by Jeff Kutok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Kutok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Kutok. The network helps show where Jeff Kutok may publish in the future.

Co-authorship network of co-authors of Jeff Kutok

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Kutok. A scholar is included among the top collaborators of Jeff Kutok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Kutok. Jeff Kutok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Postow, Michael A., Ryan J. Sullivan, Ezra E.W. Cohen, et al.. (2020). 434 Updated clinical data from the melanoma expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab. SHILAP Revista de lepidopterología. A264–A265. 10 indexed citations
2.
Sun, Amy, Laura K. Fogli, Miriam Eckstein, et al.. (2017). Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology. 138(5). 1116–1125. 64 indexed citations
3.
Rausch, Matthew, Jeremy H. Tchaicha, Thomas T. Tibbitts, et al.. (2016). Abstract B032: The PI3K-γ inhibitor, IPI-549, increases antitumor immunity by targeting tumor-associated myeloid cells and remodeling the immune-suppressive tumor microenvironment. Cancer Immunology Research. 4(11_Supplement). B032–B032. 3 indexed citations
4.
5.
Jimeno, Antonio, Glen J. Weiss, Wilson H. Miller, et al.. (2013). Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors. Clinical Cancer Research. 19(10). 2766–2774. 143 indexed citations
6.
Balakrishnan, Kumudha, Min Fu, Nathalie Y. Rosin, et al.. (2013). Inhibition Of PI3K-δ and -γ Isoforms By IPI-145 In Chronic Lymphocytic Leukemia Overcomes Signals From PI3K/AKT/S6 Pathway and Promotes Apoptosis. Blood. 122(21). 4167–4167. 3 indexed citations
7.
Lipsitz, S., Jeff Kutok, Tracie L. Miller, et al.. (2011). Impact of HFE mutations on cardiac status in survivors of childhood high-risk ALL: Dana-Farber Cancer Institute Childhood ALL 05-159.. Journal of Clinical Oncology. 29(15_suppl). 9508–9508. 2 indexed citations
8.
Guinan, Eva C., Christine M. Barbon, Leslie A. Kalish, et al.. (2011). Bactericidal/Permeability-Increasing Protein (rBPI 21 ) and Fluoroquinolone Mitigate Radiation-Induced Bone Marrow Aplasia and Death. Science Translational Medicine. 3(110). 110ra118–110ra118. 30 indexed citations
9.
Bismar, Tarek A., Francesca Demichelis, Alberto Riva, et al.. (2006). Defining Aggressive Prostate Cancer Using a 12-Gene Model. Neoplasia. 8(1). 59–68. 80 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neelima Reddy Breakdown of academic impact, for papers by Julie C. Porcher Breakdown of academic impact, for papers by Luk Cox Breakdown of academic impact, for papers by Jean Lopategui Breakdown of academic impact, for papers by Justus Duyster Breakdown of academic impact, for papers by Elisa Schipper Breakdown of academic impact, for papers by Zhiming Dong Breakdown of academic impact, for papers by Yoshiaki Chinen Breakdown of academic impact, for papers by Awatif Al‐Nafussi Breakdown of academic impact, for papers by Maria Rosaria Sapienza
Rankless by CCL
2026